Publisher: DelveInsight
Category: Prescription Drugs

Prescription Drugs market research reports by DelveInsight

(642 reports matching your criteria)
    • Ingrezza Emerging Drug Insight and Market Forecast – 2032

      Ingrezza Emerging Drug Insight and Market Forecast – 2032 “Ingrezza Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Ingrezza for Huntington’s disease in the 7MM. A detailed picture of the Ingrezza for Huntington’s disease in the 7MM, i.e., the United St ... Read More

    • Melflufen Emerging Drug Insight and Market Forecast – 2032

      Melflufen Emerging Drug Insight and Market Forecast – 2032 “Melflufen Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Melflufen for AL Amyloidosis in the 7MM. A detailed picture of the Melflufen for AL Amyloidosis in the 7MM, i.e., United States, EU5 (G ... Read More

    • MM-120 Emerging Drug Insight and Market Forecast – 2032

      MM-120 Emerging Drug Insight and Market Forecast – 2032 “MM-120 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about MM-120 for Generalized Anxiety Disorder (GAD) in the seven major markets. A detailed picture of the MM-120 for Generalized Anxiety Disorder i ... Read More

    • Cobitolimod Emerging Drug Insight and Market Forecast − 2032

      Cobitolimod Emerging Drug Insight and Market Forecast − 2032 “Cobitolimod Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about cobitolimod for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the cobitolimod for ulcerative colitis in ... Read More

    • Giredestrant Emerging Drug Insight and Market Forecast – 2032

      Giredestrant Emerging Drug Insight and Market Forecast – 2032 “Giredestrant Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Giredestrant for ER +ve HER2-ve Breast Cancer in the United States. A detailed picture of the Giredestrant for ER+ve HER2-ve Brea ... Read More

    • REMICADE Drug Insight and Market Forecast – 2032

      REMICADE Drug Insight and Market Forecast – 2032 “REMICADE Drug Insight and Market Forecast – 2032” report provides comprehensive insights about REMICADE for Rheumatoid Arthritis in the 7MM. A detailed picture of the REMICADE for Rheumatoid Arthritis in the 7MM, i.e., United States, EU4 (Germany, Fr ... Read More

    • CS1 Emerging Drug Insight and Market Forecast – 2032

      CS1 Emerging Drug Insight and Market Forecast – 2032 “CS1 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about CS1 for Pulmonary Arterial Hypertension in the 7MM. A detailed picture of the CS1 for Pulmonary Arterial Hypertension in the 7MM, i.e., United Stat ... Read More

    • Mirikizumab Emerging Drug Insight and Market Forecast − 2032

      Mirikizumab Emerging Drug Insight and Market Forecast − 2032 “Mirikizumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about mirikizumab for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the mirikizumab for ulcerative colitis in ... Read More

    • KEVZARA Drug Insight and Market Forecast – 2032

      KEVZARA Drug Insight and Market Forecast – 2032 “KEVZARA Drug Insight and Market Forecast – 2032” report provides comprehensive insights about KEVZARA for Rheumatoid Arthritis in the 7MM. A detailed picture of the KEVZARA for Rheumatoid Arthritis in the 7MM, i.e., United States, EU4 (Germany, France ... Read More

    • PIQRAY Drug Insight and Market Forecast – 2032

      PIQRAY Drug Insight and Market Forecast – 2032 “PIQRAY Drug Insight and Market Forecast – 2032” report provides comprehensive insights about PIQRAY for ER +ve HER2-ve Breast Cancer in the United States. A detailed picture of the PIQRAY for ER+ve HER2-ve Breast Cancer in the United States for the stu ... Read More

    • FS118 Emerging Drug Insight and Market Forecast – 2035

      FS118 Emerging Drug Insight and Market Forecast – 2035 “FS118 Emerging Drug Insight and Market Forecast – 2035” report provides comprehensive insights about FS118 for LAG-3 Next-generation Immunotherapies in the 7MM. A detailed picture of the FS118 for LAG-3 Next-generation Immunotherapies in the 7M ... Read More

    • JYSELECA Market Drug Insight and Market Forecast − 2032

      JYSELECA Market Drug Insight and Market Forecast − 2032 “JYSELECA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about JYSELECA for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the JYSELECA for ulcerative colitis in the 7MM, i.e., ... Read More

    • JYSELECA Drug Insight and Market Forecast – 2032

      JYSELECA Drug Insight and Market Forecast – 2032 “JYSELECA Drug Insight and Market Forecast – 2032” report provides comprehensive insights about JYSELECA for Rheumatoid Arthritis in the 6MM. A detailed picture of the JYSELECA for Rheumatoid Arthritis in the 6MM, i.e., EU4 (Germany, France, Italy, Sp ... Read More

    • VTX-801 Emerging Drug Insight and Market Forecast – 2032

      VTX-801 Emerging Drug Insight and Market Forecast – 2032 “VTX-801 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VTX-801 for Wilson’s disease in the 7MM. A detailed picture of the VTX-801 for Wilson’s disease in the 7MM, i.e., United States, EU4 (Germa ... Read More

    • SIMPONI Market Drug Insight and Market Forecast − 2032

      SIMPONI Market Drug Insight and Market Forecast − 2032 “SIMPONI Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SIMPONI for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the SIMPONI for ulcerative colitis in the 7MM, i.e., the ... Read More

    • KISQALI Drug Insight and Market Forecast – 2032

      KISQALI Drug Insight and Market Forecast – 2032 “KISQALI Drug Insight and Market Forecast – 2032” report provides comprehensive insights about KISQALI for ER +ve HER2-ve Breast Cancer in the United States. A detailed picture of the KISQALI for ER+ve HER2-ve Breast Cancer in the United States for the ... Read More

    • Zamicastat Emerging Drug Insight and Market Forecast – 2032

      Zamicastat Emerging Drug Insight and Market Forecast – 2032 “Zamicastat Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Zamicastat for Pulmonary Arterial Hypertension in the 7MM. A detailed picture of the Zamicastat for Pulmonary Arterial Hypertension i ... Read More

    • RG6139 (RO7247669) Emerging Drug Insight and Market Forecast – 2035

      RG6139 (RO7247669) Emerging Drug Insight and Market Forecast – 2035 “RG6139 (RO7247669) Emerging Drug Insight and Market Forecast – 2035” report provides comprehensive insights about RG6139 (RO7247669) for LAG-3 Next-generation Immunotherapies in the 7MM. A detailed picture of the RG6139 (RO7247669) ... Read More

    • Lerociclib Emerging Drug Insight and Market Forecast – 2032

      Lerociclib Emerging Drug Insight and Market Forecast – 2032 “Lerociclib Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Lerociclib for ER +ve HER2-ve Breast Cancer in the United States. A detailed picture of the Lerociclib for ER+ve HER2-ve Breast Cance ... Read More

    • Birtamimab Emerging Drug Insight and Market Forecast – 2032

      Birtamimab Emerging Drug Insight and Market Forecast – 2032 “Birtamimab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Birtamimab for AL Amyloidosis in the 7MM. A detailed picture of the Birtamimab for AL Amyloidosis in the 7MM, i.e., United States, EU ... Read More

    • VERZENIO Drug Insight and Market Forecast – 2032

      VERZENIO Drug Insight and Market Forecast – 2032 “VERZENIO Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VERZENIO for ER +ve HER2-ve Breast Cancer in the United States. A detailed picture of the VERZENIO for ER+ve HER2-ve Breast Cancer in the United States for ... Read More

    • HUMIRA Market Drug Insight and Market Forecast − 2032

      HUMIRA Market Drug Insight and Market Forecast − 2032 “HUMIRA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about HUMIRA for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the HUMIRA for ulcerative colitis in the 7MM, i.e., United S ... Read More

    • REMICADE Market Drug Insight and Market Forecast − 2032

      REMICADE Market Drug Insight and Market Forecast − 2032 “REMICADE Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about REMICADE for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the REMICADE for ulcerative colitis in the 7MM, i.e., ... Read More

    • ENBREL Drug Insight and Market Forecast – 2032

      ENBREL Drug Insight and Market Forecast – 2032 “ENBREL Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ENBREL for Rheumatoid Arthritis in the 7MM. A detailed picture of the ENBREL for Rheumatoid Arthritis in the 7MM, i.e., United States, EU4 (Germany, France, It ... Read More

    • Capivasertib Emerging Drug Insight and Market Forecast – 2032

      Capivasertib Emerging Drug Insight and Market Forecast – 2032 “Capivasertib Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Capivasertib for ER +ve HER2-ve Breast Cancer in the United States. A detailed picture of the Capivasertib for ER+ve HER2-ve Brea ... Read More

4 5 6 7 8 9 10 11 12 13

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings